News

Shionogi’s treatment is said to be effective even after 48 hours from the emergence of symptoms, unlike the “Tamiflu” influenza medication, which must be administered within 48 hours.

HHS is also in talks with other manufacturers to increase capacity. These manufacturers will receive another $150 million to produce pilot lots of vaccine and to pay for

The agreement will be finalized by the end of May 2009. NanoTherapies is engaged in the development of life-changing therapies for cancer treatment based on an evolving set

Hologic’s planned importation, use, sale or offer to sell of Adiana system will infringe various patents owned by Conceptus including U.S. Patent Nos. 7506650, 7428904, 7237552, 6709667 and

Effective July 2009, Drug Discovery Research facility in Hyderabad will be known as Aurigene – Hyderabad. Thus, Aurigene will now operate from two locations: Bangalore and Hyderabad. In

As part of this acquisition, NuSil will transfer the manufacturing of the Bluestar Silicones pharmaceutical Simethicone business to NuSil’s FDA registered facility in Bakersfield, California. The company will

The trials, termed as EXPEDITION and EXPEDITION 2, are identical multicenter, randomized, double-blind and placebo-controlled trials. Each will include a treatment period that lasts one and half year

Cougar is currently conducting two Phase III trials for abiraterone acetate for the treatment of prostate cancer. The first Phase III trial is testing abiraterone acetate in patients

Last October, the company submitted a new drug application to the US Food and Drug Administration (FDA) requesting marketing approval of Qutenza. In December 2008, it was accepted